Back

Myocardial iron depletion exacerbates end-stage heart failure by promoting adverse remodeling and worsening mitochondrial function

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Comorbidities in Heart Failure: What Could Be Done Better? Comorbidities ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Hao Zhang

University of Alberta, Edmonton (Canada)

2 More presentations in this session

Presentation thumbnail
Association between use of beta-blockers and mortality/morbidity in patients with heart failure with reduced, midrange or preserved ejection fraction and advanced chronic kidney disease
Mr E. Fu (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
New-onset type 2 diabetes in heart failure: impact of heart failure and death versus ischemic events - a danish nationwide cohort study.
Mrs B. Zareini (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities in Heart Failure: What Could Be Done Better?

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Preemptive iron supplementation prevents cardiac iron deficiency and adverse remodelling after myocardial infarction
21 May 2023
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
17 May 2025
thumbnail
Congress Presentation
Association between abnormal fatty acid metabolism and myocardial triglyceride accumulation in patients with chronic heart failure: a study using BMIPP and 1H-MRS
29 August 2025
thumbnail
Congress Presentation
Iron-regulatory proteins secure iron availability in skeletal muscle to preserve exercise tolerance in heart failure
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources